4//SEC Filing
Burrows Scott L 4
Accession 0001636282-25-000010
CIK 0001636282other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:36 PM ET
Size
5.6 KB
Accession
0001636282-25-000010
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-15+95,500→ 95,500 totalExercise: $21.66Exp: 2035-01-15→ Common Stock (95,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001853327
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:36 PM ET
- Size
- 5.6 KB